GILEAD SCIENCES, INC. — Director's Dealing 2014

Oct 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-10-01

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-01	Common Stock	M	31000	$23.755	Acquired	153694	Direct
2014-10-01	Common Stock	S	25405	$105.8341	Disposed	128289	Direct
2014-10-01	Common Stock	S	5395	$106.588	Disposed	122894	Direct
2014-10-01	Common Stock	S	200	$107.4650	Disposed	122694	Direct
2014-10-01	Common Stock	S	1751	$105.9067	Disposed	120943	Direct
2014-10-01	Common Stock	S	249	$106.6894	Disposed	120694	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-01	Non-Qualified Stock Option (right to buy)	$23.755	M	31000	Disposed	2020-01-28	Common Stock (31000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $105.33 to $106.3291. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $106.33 to $107.29. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $107.43 to $107.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $105.39 to $106.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F7: Sale prices reported for the transactions reported here range from $106.40 to $106.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.